Galectin Therapeutics GALT
NASDAQ GALT
$3.38 +0.01 (+0.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Dividends Paid - Common and Prefferd (2019)

Updated

Analysis

Galectin Therapeutics (GALT) Dividends Paid - Common and Prefferd (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div Paid (Total) (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 1.55 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 3.23 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 3.07 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 2.14 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 2.87 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 6.58 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 1.36 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 2.45 Bn
10 Galectin Therapeutics 214.62 Mn 157.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 2,000.00
Jun 30, 2019 -1,000.00
Mar 31, 2019 -395,000.00
API Access

Galectin Therapeutics Dividends Paid - Common and Prefferd API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-paid-common-and-prefferd&ticker=GALT&period=max&api_key=YOUR_API_KEY